Discover 2,314 paid clinical trials in Oceanside, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,314
Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation
for
Locally Advanced, Unresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation,
Location: Los Alamitos CA, Los Angeles CA, Houston TX, Chicago IL,
Sponsor: Institut de Recherches Internationales Servier
Sex: All
Age: 18+
Code: NCT06501625
Phase1, Phase2, Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for
Colorectal Neoplasms
Location: Los Alamitos CA, Torrance CA, Los Angeles CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06662786
Phase3, Recruiting
An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Los Alamitos CA, Los Angeles CA, Irving TX, Houston TX,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06589596
Phase1, Recruiting
A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
for
Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma,
Location: Fullerton CA, Santa Monica CA, Stanford CA, Dallas TX,
Sponsor: TORL Biotherapeutics, LLC
Sex: All
Age: 18+
Code: NCT07439653
Phase1, Phase2, Recruiting
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
for
Renal Cell Carcinoma
Location: Fullerton CA, Los Angeles CA, Omaha NE,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07227402
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer
for
Advanced Solid Tumor, Hepatocellular Carcinoma
Location: Fullerton CA, Torrance CA, Los Angeles CA, Phoenix AZ,
Sponsor: TORL Biotherapeutics, LLC
Sex: All
Age: 18+
Code: NCT06005740
Phase1, Recruiting
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
for
Melanoma Stage IV, Solid Tumor
Location: Fullerton CA, Los Angeles CA, Bakersfield CA,
Sponsor: Georgiamune Inc
Sex: All
Age: 18+
Code: NCT06425926
Phase1, Phase2, Recruiting
Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer
for
Metastatic Colorectal Adenocarcinoma,
Location: Fullerton CA, Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT06336902
Phase1, Recruiting
Telerehabilitation Early After Stroke
for
Cerebral Stroke
Location: Fullerton CA
Sponsor: TRCare, Inc.
Sex: All
Age: 18+
Code: NCT05625438
Recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: Fullerton CA, Duarte CA, Los Angeles CA,
Sponsor: TORL Biotherapeutics, LLC
Sex: Female
Age: 18+
Code: NCT06690775
Phase2, Recruiting
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
for
IgA Nephropathy
Location: Chula Vista CA, Arvada CO, Denver CO, Houston TX,
Sponsor: Jade Biosciences, Inc.
Sex: All
Age: 18 - 60
Code: NCT07541287
Phase2, Recruiting
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
for
Prostate Cancer
Location: Fullerton CA, Duarte CA, San Francisco CA, Murray UT,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT04221542
Phase1, Recruiting
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
for
Squamous Non-small-cell Lung Cancer,
Location: Fullerton CA, Los Angeles CA, Scottsdale AZ, Chicago IL,
Sponsor: Alentis Therapeutics AG
Sex: All
Age: 18+
Code: NCT06747585
Phase1, Phase2, Recruiting
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
for
Coronary Artery Disease,
Location: Loma Linda CA, Thousand Oaks CA, Sacramento CA,
Sponsor: Supira Medical
Sex: All
Age: 18 - 70+
Code: NCT07296744
Recruiting
New
FT839 in Autoimmune Diseases
for
ANCA-Associated Vasculitis (AAV),
Location: Fullerton CA
Sponsor: Fate Therapeutics
Sex: All
Age: 18 - 70
Code: NCT07800871
Phase1, Phase2, Recruiting
A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
for
Obesity and Obesity-related Medical Conditions
Location: Cypress CA
Sponsor: Pfizer
Sex: All
Age: 18 - 70+
Code: NCT06924320
Phase1, Phase2, Recruiting
Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
for
Obesity
Location: Cypress CA
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07225816
Phase1, Recruiting
Study of OsrhAAT or Placebo in Healthy Volunteers
for
Emphysema Secondary to Congenital AATD
Location: Cypress CA
Sponsor: Healthgen Biotechnology Corp.
Sex: All
Age: 18 - 55
Code: NCT05315921
Phase1, Recruiting
Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With Asthma
for
Safety in Asthma Patients
Location: Anaheim CA
Sponsor: Aspeya, Inc.
Sex: All
Age: 18 - 55
Code: NCT07665892
Phase1, Recruiting
A Clinical Trial of MK-4082 in Healthy Participants (MK-4082-005)